Free Trial

Immatics (IMTX) News Today

Immatics logo
$7.17 -0.25 (-3.37%)
As of 01/3/2025 05:39 PM Eastern
Immatics stock logo
Immatics (NASDAQ:IMTX) Sets New 1-Year Low - Should You Sell?
Immatics (NASDAQ:IMTX) Sets New 52-Week Low - Time to Sell?
Immatics stock logo
Immatics (NASDAQ:IMTX) Short Interest Update
Immatics (NASDAQ:IMTX - Get Free Report) saw a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 8,190,000 shares, a growth of 6.4% from the November 15th total of 7,700,000 shares. Based on an average daily trading volume, of 596,800 shares, the short-interest ratio is presently 13.7 days.
Mizuho Securities Sticks to Its Buy Rating for Immatics (IMTX)
Immatics stock logo
Immatics (NASDAQ:IMTX) Stock Price Down 4.2% - Time to Sell?
Immatics (NASDAQ:IMTX) Stock Price Down 4.2% - Should You Sell?
Immatics stock logo
Frazier Life Sciences Management L.P. Has $15.46 Million Stake in Immatics (NASDAQ:IMTX)
Frazier Life Sciences Management L.P. increased its holdings in shares of Immatics (NASDAQ:IMTX - Free Report) by 17.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,354,711 shares of the company's stock after acquiri
Immatics stock logo
Immatics (NASDAQ:IMTX) Holdings Lifted by Wellington Management Group LLP
Wellington Management Group LLP boosted its holdings in shares of Immatics (NASDAQ:IMTX - Free Report) by 1.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,681,183 shares of the company's stock after buying an addition
Immatics stock logo
Walleye Capital LLC Sells 137,200 Shares of Immatics (NASDAQ:IMTX)
Walleye Capital LLC trimmed its holdings in Immatics (NASDAQ:IMTX - Free Report) by 32.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 282,193 shares of the company's stock after selling 137,200 shares during the quarter
Immatics stock logo
Braidwell LP Takes $18.80 Million Position in Immatics (NASDAQ:IMTX)
Braidwell LP acquired a new stake in shares of Immatics (NASDAQ:IMTX - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,647,565 shares of the company's stock, valued at approximately $18,799,00
Immatics stock logo
Immatics (NASDAQ:IMTX) is Vestal Point Capital LP's 9th Largest Position
Vestal Point Capital LP increased its position in shares of Immatics (NASDAQ:IMTX - Free Report) by 36.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,750,000 shares of the company's stock after purchasing an additional 1,000,000
Immatics stock logo
Immatics (NASDAQ:IMTX) Upgraded by The Goldman Sachs Group to "Strong-Buy" Rating
The Goldman Sachs Group upgraded shares of Immatics to a "strong-buy" rating in a research report on Monday.
Immatics moved to Buy from Not Rated at Goldman Sachs
Immatics N.V. Reports Strong Q3 2024 Progress and Financials
Immatics: Promising Pipeline and Financial Health Justify Buy Rating
Immatics stock logo
Cantor Fitzgerald Forecasts Higher Earnings for Immatics
Immatics (NASDAQ:IMTX - Free Report) - Equities researchers at Cantor Fitzgerald raised their FY2024 earnings per share estimates for Immatics in a report issued on Tuesday, November 19th. Cantor Fitzgerald analyst E. Schmidt now anticipates that the company will post earnings of ($0.68) per shar
Immatics stock logo
FY2024 EPS Estimates for Immatics Raised by Leerink Partnrs
Immatics (NASDAQ:IMTX - Free Report) - Investment analysts at Leerink Partnrs upped their FY2024 earnings per share estimates for shares of Immatics in a research report issued to clients and investors on Monday, November 18th. Leerink Partnrs analyst J. Chang now forecasts that the company will
Immatics price target lowered to $15 from $16 at BofA
Jefferies Releases a Buy Rating on Immatics (IMTX)
Immatics stock logo
Immatics (NASDAQ:IMTX) Price Target Cut to $15.00 by Analysts at Bank of America
Bank of America lowered their price target on Immatics from $16.00 to $15.00 and set a "buy" rating for the company in a research report on Tuesday.
Immatics price target lowered to $18 from $19 at Leerink
Immatics Sees Revenue Surge Despite R&D Expenses
Immatics announces clinical data on TCER IMA402 targeting PRAME
Immatics stock logo
Immatics (NASDAQ:IMTX) Reaches New 1-Year Low - Here's Why
Immatics (NASDAQ:IMTX) Reaches New 52-Week Low - Here's What Happened
Immatics Unveils Promising TCR-T Therapy Developments
Immatics stock logo
abrdn plc Invests $2.66 Million in Immatics (NASDAQ:IMTX)
abrdn plc purchased a new position in Immatics (NASDAQ:IMTX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 232,900 shares of the company's stock, valued at approx
Immatics N.V. (IMTX)
Perceptive Advisors LLC Reduces Stake in Immatics NV
Immatics stock logo
Immatics (NASDAQ:IMTX) Sees Significant Decline in Short Interest
Immatics (NASDAQ:IMTX - Get Free Report) was the target of a large decline in short interest in September. As of September 30th, there was short interest totalling 9,520,000 shares, a decline of 11.9% from the September 15th total of 10,800,000 shares. Based on an average trading volume of 324,000 shares, the short-interest ratio is currently 29.4 days.
Immatics stock logo
Cubist Systematic Strategies LLC Acquires Shares of 206,920 Immatics (NASDAQ:IMTX)
Cubist Systematic Strategies LLC acquired a new stake in Immatics (NASDAQ:IMTX - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm acquired 206,920 shares of the company's stock, valued at approximately $2,404,000. Cubist Systematic Strategie
Immatics: A Promising TCR Pipeline
Immatics Advances IMA203 to Phase 3 Trial in Melanoma
Immatics stock logo
Immatics (NASDAQ:IMTX) Sees Strong Trading Volume - Here's Why
Immatics (NASDAQ:IMTX) Sees Large Volume Increase - Here's What Happened
Immatics Reports Updated Phase 1b Data Of IMA203 In Melanoma Patients
Immatics stock logo
Immatics (NASDAQ:IMTX) Shares Gap Down - Time to Sell?
Immatics (NASDAQ:IMTX) Shares Gap Down - Here's Why
Immatics Announces Proposed $150 Million Public Offering
Get Immatics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMTX and its competitors with MarketBeat's FREE daily newsletter.


IMTX Media Mentions By Week

IMTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMTX
News Sentiment

0.00

0.87

Average
Medical
News Sentiment

IMTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMTX Articles
This Week

0

2

IMTX Articles
Average Week

Get Immatics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:IMTX) was last updated on 1/4/2025 by MarketBeat.com Staff
From Our Partners